skip to main content
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover tipo de recurso: Artigos remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study
Material Type:
Artigo
Adicionar ao Meu Espaço

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

Rivkin, S E ; Green, S ; Metch, B ; Cruz, A B ; Abeloff, M D ; Jewell, W R ; Costanzi, J J ; Farrar, W B ; Minton, J P ; Osborne, C K

Journal of clinical oncology, 1994-10, Vol.12 (10), p.2078-2085 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Sem texto completo

2
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study

Rivkin, S E ; Green, S ; Metch, B ; Glucksberg, H ; Gad-el-Mawla, N ; Constanzi, J J ; Hoogstraten, B ; Athens, J ; Maloney, T ; Osborne, C K

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1229-1238 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Sem texto completo

3
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study
Material Type:
Artigo
Adicionar ao Meu Espaço

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

RAVDIN, PM ; GREEN, S ; DORR, TM ; MCGUIRE, WL ; FABIAN, C ; PUGH, RP ; CARTER, RD ; RIVKIN, SE ; BORST ; BELT, RJ ; METCH, B ; OSBORNE, CK

Journal of clinical oncology, 1992-08, Vol.10 (8), p.1284-1291 [Periódico revisado por pares]

ALEXANDRIA: American Society of Clinical Oncology

Sem texto completo

4
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study
Material Type:
Artigo
Adicionar ao Meu Espaço

One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study

RIVKIN, S. E ; GREEN, S ; METCH, B ; JEWELL, W. R ; COSTANZI, J. J ; ALTMAN, S. J ; MINTON, J. P ; O'BRYAN, R. M ; OSBORNE, C. K

Journal of clinical oncology, 1993-09, Vol.11 (9), p.1710-1716 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

5
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fuorouracil versus methotrexate in advanced squamous-cell carcinoma of the heat and neck : a southwest oncology group study
Material Type:
Artigo
Adicionar ao Meu Espaço

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fuorouracil versus methotrexate in advanced squamous-cell carcinoma of the heat and neck : a southwest oncology group study

FORASTIERE, A. A ; METCH, B ; VON HOFF, D. D ; SCHULLER, D. E ; ENSLEY, J. F ; HUTCHINS, L. F ; TRIOZZI, P ; KISH, J. A ; MCCLURE, S ; VONFELDT, E ; WILLIAMSON, S. K

Journal of clinical oncology, 1992, Vol.10 (8), p.1245-1251 [Periódico revisado por pares]

Baltimore, MD: Lippincott Williams & Wilkins

Sem texto completo

Buscando em bases de dados remotas. Favor aguardar.